These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 15039277

  • 1. A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Soda Y, Tani K, Bai Y, Saiki M, Chen M, Izawa K, Kobayashi S, Takahashi S, Uchimaru K, Kuwabara T, Warashina M, Tanabe T, Miyoshi H, Sugita K, Nakazawa S, Tojo A, Taira K, Asano S.
    Blood; 2004 Jul 15; 104(2):356-63. PubMed ID: 15039277
    [Abstract] [Full Text] [Related]

  • 2. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS, Greene JM, McConnell TS, Willman CL.
    Leukemia; 1999 Dec 15; 13(12):2007-11. PubMed ID: 10602422
    [Abstract] [Full Text] [Related]

  • 3. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG, MacLeod RA, Uphoff CC.
    Leuk Res; 1999 Mar 15; 23(3):207-15. PubMed ID: 10071072
    [Abstract] [Full Text] [Related]

  • 4. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
    Suh SP, Kee SJ, Lim WH, Song JW, Lee SK, Kim JP, Shin JH, Ryang DW.
    Clin Chem Lab Med; 2000 Sep 15; 38(9):939-44. PubMed ID: 11097354
    [Abstract] [Full Text] [Related]

  • 5. Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.
    Snyder DS, Wu Y, McMahon R, Yu L, Rossi JJ, Forman SJ.
    Biol Blood Marrow Transplant; 1997 Oct 15; 3(4):179-86. PubMed ID: 9360779
    [Abstract] [Full Text] [Related]

  • 6. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
    Kirk JA, Radich J, Edmands S, Lee A, VanDevanter DR, Reems JA, Bryant EM.
    Am J Hematol; 1996 Jul 15; 52(3):129-34. PubMed ID: 8756076
    [Abstract] [Full Text] [Related]

  • 7. Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
    Hidaka M, Inokuchi K, Uoshima N, Takahashi N, Yoshida N, Ota S, Nakamae H, Iwasaki H, Watanabe K, Kosaka Y, Komatsu N, Meguro K, Najima Y, Eto T, Kondo T, Kimura S, Yoshida C, Ishikawa Y, Sawa M, Hata T, Horibe K, Iida H, Shimomura T, Dobashi N, Sugiura I, Makiyama J, Miyagawa N, Sato A, Ito R, Matsumura I, Kanakura Y, Naoe T.
    Jpn J Clin Oncol; 2024 Feb 07; 54(2):153-159. PubMed ID: 37986553
    [Abstract] [Full Text] [Related]

  • 8. The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia.
    Rafiei A, Mian AA, Döring C, Metodieva A, Oancea C, Thalheimer FB, Hansmann ML, Ottmann OG, Ruthardt M.
    PLoS Genet; 2015 Apr 07; 11(4):e1005144. PubMed ID: 25919613
    [Abstract] [Full Text] [Related]

  • 9. Allosterically controlled single-chained maxizymes with extremely high and specific activity.
    Kuwabara T, Hamada M, Warashina M, Taira K.
    Biomacromolecules; 2001 Apr 07; 2(3):788-99. PubMed ID: 11710033
    [Abstract] [Full Text] [Related]

  • 10. Allosterically controllable maxizyme-mediated suppression of progression of leukemia in mice.
    Kuwabara T, Tanabe T, Warashina M, Xiong KX, Tani K, Taira K, Asano S.
    Biomacromolecules; 2001 Apr 07; 2(4):1220-8. PubMed ID: 11777396
    [Abstract] [Full Text] [Related]

  • 11. Specific killing of Ph+ chronic myeloid leukemia cells by a lentiviral vector-delivered anti-bcr/abl small hairpin RNA.
    Li MJ, McMahon R, Snyder DS, Yee JK, Rossi JJ.
    Oligonucleotides; 2003 Apr 07; 13(5):401-9. PubMed ID: 15000831
    [Abstract] [Full Text] [Related]

  • 12. Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia.
    Tuszynski A, Dhut S, Young BD, Lister TA, Rohatiner AZ, Amess JA, Chaplin T, Dorey E, Gibbons B.
    Leukemia; 1993 Oct 07; 7(10):1504-8. PubMed ID: 8412311
    [Abstract] [Full Text] [Related]

  • 13. Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector.
    Uchida N, Hanawa H, Dan K, Inokuchi K, Shimada T.
    J Nippon Med Sch; 2009 Jun 07; 76(3):134-47. PubMed ID: 19602820
    [Abstract] [Full Text] [Related]

  • 14. A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo.
    Kuwabara T, Warashina M, Tanabe T, Tani K, Asano S, Taira K.
    Mol Cell; 1998 Nov 07; 2(5):617-27. PubMed ID: 9844634
    [Abstract] [Full Text] [Related]

  • 15. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M, Cao X, Estrov Z, Jeha S, Jin G, O'Brien S, Talpaz M, Arlinghaus RB, Lydon NB, Kantarjian H.
    Clin Cancer Res; 1998 Jul 07; 4(7):1661-72. PubMed ID: 9676840
    [Abstract] [Full Text] [Related]

  • 16. The role of molecular techniques in the clinical management of leukemia. Lessons from the Philadelphia chromosome.
    Westbrook CA.
    Cancer; 1992 Sep 15; 70(6 Suppl):1695-700. PubMed ID: 1516023
    [Abstract] [Full Text] [Related]

  • 17. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ, Hirsch-Ginsberg CF, Xian YM, Stass SA, Champlin RE, Giralt SA, McCredie KB, Campbell ML, Arlinghaus RB.
    Hematol Pathol; 1993 Sep 15; 7(2):91-106. PubMed ID: 8340287
    [Abstract] [Full Text] [Related]

  • 18. BCR/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of chronic myelogenous leukemia.
    Salesse S, Verfaillie CM.
    Mol Cancer Ther; 2003 Feb 15; 2(2):173-82. PubMed ID: 12589034
    [Abstract] [Full Text] [Related]

  • 19. Quantification of minimal residual disease in patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay.
    Yokota H, Tsuno NH, Tanaka Y, Fukui T, Kitamura K, Hirai H, Osumi K, Itou N, Satoh H, Okabe M, Nakahara K.
    Leukemia; 2002 Jun 15; 16(6):1167-75. PubMed ID: 12040449
    [Abstract] [Full Text] [Related]

  • 20. Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients.
    Janssen JW, Fonatsch C, Ludwig WD, Rieder H, Maurer J, Bartram CR.
    Leukemia; 1992 May 15; 6(5):463-4. PubMed ID: 1593911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.